US Stock MarketDetailed Quotes

IDEXX Laboratories Inc (IDXX)

Watchlist
  • 567.460
  • +6.660+1.19%
Close May 1 16:00 ET
  • 567.460
  • 0.0000.00%
Post 17:14 ET
45.07BMarket Cap43.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IDEXX Laboratories Inc (IDXX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
10.42%4.3B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
6.46%3.9B
5.84%954.29M
6.56%975.54M
6.35%1B
7.10%964.1M
Operating revenue
10.42%4.3B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
6.46%3.9B
5.84%954.29M
6.56%975.54M
6.35%1B
7.10%964.1M
Cost of revenue
8.27%1.64B
12.73%432.47M
11.17%421.89M
7.88%414.73M
1.08%375.05M
3.24%1.52B
2.18%383.63M
3.25%379.51M
3.68%384.42M
3.86%371.03M
Gross profit
11.80%2.66B
15.33%658.11M
14.65%683.35M
12.21%694.73M
5.11%623.38M
8.63%2.38B
8.46%570.66M
8.77%596.04M
8.08%619.16M
9.23%593.07M
Operating expense
3.91%1.3B
10.85%342.51M
12.45%328.51M
-9.48%321.69M
4.33%306.85M
14.43%1.25B
10.01%308.97M
7.13%292.15M
28.42%355.36M
12.01%294.11M
Selling and administrative expenses
1.70%1.05B
9.72%275.68M
11.31%265.09M
-13.38%259.79M
2.61%247.78M
14.29%1.03B
9.69%251.25M
5.98%238.17M
30.28%299.91M
10.82%241.48M
-Selling and marketing expense
9.35%643.55M
11.29%167.06M
8.80%159.16M
12.93%161.11M
4.53%156.22M
3.96%588.51M
5.69%150.11M
7.80%146.28M
1.52%142.67M
1.12%149.45M
-General and administrative expense
-8.48%404.79M
7.39%108.62M
15.29%105.94M
-37.24%98.68M
-0.50%91.56M
31.70%442.29M
16.22%101.14M
3.20%91.89M
75.36%157.24M
31.27%92.02M
Research and development costs
14.29%251.21M
15.77%66.83M
17.48%63.42M
11.63%61.9M
12.21%59.06M
15.10%219.79M
11.42%57.73M
12.53%53.98M
19.23%55.45M
17.84%52.64M
Operating profit
20.53%1.36B
20.60%315.61M
16.77%354.85M
41.41%373.05M
5.88%316.53M
2.84%1.13B
6.68%261.69M
10.39%303.89M
-10.92%263.8M
6.62%298.96M
Net non-operating interest income expense
-93.68%-35.84M
-62.73%-8.62M
-102.19%-10.08M
-125.37%-10.69M
-85.40%-6.45M
48.53%-18.51M
5.95%-5.3M
32.59%-4.98M
53.55%-4.75M
72.63%-3.48M
Non-operating interest income
-76.30%3.01M
-73.31%587K
-78.63%580K
-81.31%627K
-72.56%1.22M
125.60%12.7M
-39.44%2.2M
116.25%2.71M
925.69%3.35M
965.38%4.43M
Non-operating interest expense
24.51%38.85M
22.83%9.21M
38.43%10.66M
39.78%11.32M
-3.10%7.67M
-24.95%31.21M
-19.07%7.5M
-10.99%7.7M
-23.17%8.1M
-39.73%7.91M
Other net income (expense)
Income before tax
19.31%1.32B
19.73%306.98M
15.34%344.77M
39.87%362.35M
4.94%310.08M
4.59%1.11B
6.98%256.39M
11.58%298.91M
-9.40%259.06M
10.38%295.48M
Income tax
19.26%264.73M
46.12%58.79M
6.20%70.16M
22.61%68.36M
12.53%67.41M
2.70%221.96M
-10.87%40.24M
18.70%66.07M
-9.62%55.76M
11.68%59.9M
Net income
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
10.06%235.58M
Net income continuous Operations
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
10.06%235.58M
Minority interest income
Net income attributable to the parent company
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
10.06%235.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.33%1.06B
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
5.07%887.87M
11.12%216.15M
9.71%232.84M
-9.34%203.3M
10.06%235.58M
Basic earnings per share
22.28%13.17
17.80%3.11
21.20%3.43
48.78%3.66
4.93%2.98
5.90%10.77
12.82%2.64
10.98%2.83
-8.89%2.46
10.08%2.84
Diluted earnings per share
22.59%13.08
17.56%3.08
21.43%3.4
48.77%3.63
5.34%2.96
6.06%10.67
12.93%2.62
10.67%2.8
-8.61%2.44
10.20%2.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 10.42%4.3B14.28%1.09B13.29%1.11B10.55%1.11B3.56%998.43M6.46%3.9B5.84%954.29M6.56%975.54M6.35%1B7.10%964.1M
Operating revenue 10.42%4.3B14.28%1.09B13.29%1.11B10.55%1.11B3.56%998.43M6.46%3.9B5.84%954.29M6.56%975.54M6.35%1B7.10%964.1M
Cost of revenue 8.27%1.64B12.73%432.47M11.17%421.89M7.88%414.73M1.08%375.05M3.24%1.52B2.18%383.63M3.25%379.51M3.68%384.42M3.86%371.03M
Gross profit 11.80%2.66B15.33%658.11M14.65%683.35M12.21%694.73M5.11%623.38M8.63%2.38B8.46%570.66M8.77%596.04M8.08%619.16M9.23%593.07M
Operating expense 3.91%1.3B10.85%342.51M12.45%328.51M-9.48%321.69M4.33%306.85M14.43%1.25B10.01%308.97M7.13%292.15M28.42%355.36M12.01%294.11M
Selling and administrative expenses 1.70%1.05B9.72%275.68M11.31%265.09M-13.38%259.79M2.61%247.78M14.29%1.03B9.69%251.25M5.98%238.17M30.28%299.91M10.82%241.48M
-Selling and marketing expense 9.35%643.55M11.29%167.06M8.80%159.16M12.93%161.11M4.53%156.22M3.96%588.51M5.69%150.11M7.80%146.28M1.52%142.67M1.12%149.45M
-General and administrative expense -8.48%404.79M7.39%108.62M15.29%105.94M-37.24%98.68M-0.50%91.56M31.70%442.29M16.22%101.14M3.20%91.89M75.36%157.24M31.27%92.02M
Research and development costs 14.29%251.21M15.77%66.83M17.48%63.42M11.63%61.9M12.21%59.06M15.10%219.79M11.42%57.73M12.53%53.98M19.23%55.45M17.84%52.64M
Operating profit 20.53%1.36B20.60%315.61M16.77%354.85M41.41%373.05M5.88%316.53M2.84%1.13B6.68%261.69M10.39%303.89M-10.92%263.8M6.62%298.96M
Net non-operating interest income expense -93.68%-35.84M-62.73%-8.62M-102.19%-10.08M-125.37%-10.69M-85.40%-6.45M48.53%-18.51M5.95%-5.3M32.59%-4.98M53.55%-4.75M72.63%-3.48M
Non-operating interest income -76.30%3.01M-73.31%587K-78.63%580K-81.31%627K-72.56%1.22M125.60%12.7M-39.44%2.2M116.25%2.71M925.69%3.35M965.38%4.43M
Non-operating interest expense 24.51%38.85M22.83%9.21M38.43%10.66M39.78%11.32M-3.10%7.67M-24.95%31.21M-19.07%7.5M-10.99%7.7M-23.17%8.1M-39.73%7.91M
Other net income (expense)
Income before tax 19.31%1.32B19.73%306.98M15.34%344.77M39.87%362.35M4.94%310.08M4.59%1.11B6.98%256.39M11.58%298.91M-9.40%259.06M10.38%295.48M
Income tax 19.26%264.73M46.12%58.79M6.20%70.16M22.61%68.36M12.53%67.41M2.70%221.96M-10.87%40.24M18.70%66.07M-9.62%55.76M11.68%59.9M
Net income 19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M10.06%235.58M
Net income continuous Operations 19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M10.06%235.58M
Minority interest income
Net income attributable to the parent company 19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M10.06%235.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.33%1.06B14.82%248.19M17.94%274.61M44.61%293.99M3.01%242.68M5.07%887.87M11.12%216.15M9.71%232.84M-9.34%203.3M10.06%235.58M
Basic earnings per share 22.28%13.1717.80%3.1121.20%3.4348.78%3.664.93%2.985.90%10.7712.82%2.6410.98%2.83-8.89%2.4610.08%2.84
Diluted earnings per share 22.59%13.0817.56%3.0821.43%3.448.77%3.635.34%2.966.06%10.6712.93%2.6210.67%2.8-8.61%2.4410.20%2.81
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -